Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05137743 · ClinicalTrials.gov registry record · NA
Pilot Test of Apnea and Insomnia Relief for Veterans With Gulf War Illness
A NA study of Gulf War Illness, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT05137743: Active NA study of Gulf War Illness, sponsored by University of California, San Francisco.
NCT05137743 is a NA study of Gulf War Illness that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 80 participants, below the 124-participant average among 14 other Gulf War Illness trials with a reported enrollment target (35% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05137743, a NA study of Gulf War Illness, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine whether a behavioral sleep treatment improves sleep and other Gulf War Illness (GWI) symptoms in Gulf War Veterans with GWI.
Primary Outcome
Due to its novelty, complexity, and variability, no single measure of severity addresses all possible presentations of Gulf War Illness (GWI). Therefore, we used the symptom portion of the Kansas Gulf War Military History and Health Questionnaire to query about fatigue/sleep problems, somatic pain, skin abnormalities, gastrointestinal, respiratory, and neurologic/cognitive/mood symptoms, based on the Kansas GWI and CDC CMI case definition. To assess current GWI symptoms, participants will be ask
Conditions Studied
Interventions
- BEHAVIORAL Apnea and Insomnia Relief (AIR)
- BEHAVIORAL Sleep Education (SE)
Study Locations (1)
California
- VA Health Care System - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2022-02-15 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
What the registry record for NCT05137743 still lists
NCT05137743 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 124-participant average among 14 other Gulf War Illness trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Gulf War Illness appearing as the primary indexed condition, and to 2 interventions - of which Apnea and Insomnia Relief (AIR) is the first listed.
NCT05137743 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05137743 about?
NCT05137743 is a clinical study titled "Pilot Test of Apnea and Insomnia Relief for Veterans With Gulf War Illness". The purpose of this study is to determine whether a behavioral sleep treatment improves sleep and other Gulf War Illness (GWI) symptoms in Gulf War Veterans with GWI.
What is the current status of trial NCT05137743?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-02-15. Estimated completion is 2026-07-31.
What conditions does trial NCT05137743 study?
This clinical trial studies the following conditions: Gulf War Illness.
What interventions are being tested in trial NCT05137743?
The interventions under investigation include: Apnea and Insomnia Relief (AIR) (BEHAVIORAL), Sleep Education (SE) (BEHAVIORAL).
Who is sponsoring clinical trial NCT05137743?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05137743 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gulf War Illness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05137743's enrollment target sits among peer trials
80 9th of 14 higher than 5 of 14 other Gulf War Illness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Gulf War Illness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nicotinamide Riboside Clinical Trial for GWI
RECRUITING · NA
-
Mechanisms of Gulf War Illness
RECRUITING · NA
-
Curcumin, Resveratrol, and Stinging Nettle as Treatments for GWI
ACTIVE NOT RECRUITING · NA
-
Collaborative Specialty Care for Gulf War Illness
ACTIVE NOT RECRUITING · NA
-
Confirmation of Diet as a Treatment for Gulf War Illness
RECRUITING · Phase 3
-
NIH Investigative Deep Phenotyping Study of Gulf War Veteran Health (Project NIH IN-DEPTH)
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI